HON

Honeywell

$231.24

+1.68%
Jun 25, 2026
Bobby Quantitative Model
Honeywell International Inc. is a global industrial conglomerate operating through four core segments: Aerospace Technologies, Industrial Automation, Energy and Sustainability Solutions, and Building Automation. The company is a dominant player with one of the world's largest installed equipment bases, deriving significant recurring revenue from aftermarket services. The current investor narrative is overwhelmingly focused on the company's strategic portfolio transformation, specifically the board-approved spinoff of its high-growth Aerospace unit, a move widely anticipated to unlock shareholder value by creating two more focused entities and driving potential valuation expansion for both.

People also watch

Valmont Industries

Valmont Industries

VMI

Analysis
Caterpillar Inc.

Caterpillar Inc.

CAT

Analysis
GE Aerospace

GE Aerospace

GE

Analysis
RTX

RTX

RTX

Analysis

BobbyInvestment Opinion: Should I buy HON Today?

Rating & Thesis: HON is a Hold. The core thesis is that the compelling long-term value-creation story from the Aerospace spinoff is currently offset by near-term execution risks, revenue softness, and a full valuation, warranting a wait-and-see approach despite the bullish analyst sentiment and +30% implied upside to the average target.

Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is rich at a forward P/E of 20.01x and a trailing P/E of 26.36x, above its own historical range. Second, recent revenue growth has turned negative (-3.28% YoY in Q4). Third, while profitability is strong (17.54% operating margin), it is being tested. Fourth, the stock has severely underperformed the market (-15.48 relative strength), indicating weak momentum. The substantial analyst target upside suggests potential, but it is contingent on successful spinoff execution.

Risks & Conditions: The two biggest risks are spinoff execution missteps and a further deterioration in organic growth, either of which could crush the premium multiple. This Hold rating would upgrade to a Buy if the forward P/E compressed below 18x on market weakness, or if post-spinoff clarity reveals faster-than-expected synergy capture and growth acceleration in the separate entities. It would downgrade to a Sell if quarterly revenue declines accelerate beyond -5% or if the spinoff timeline is significantly delayed. Relative to its history and the current growth profile, the stock is fairly valued to slightly overvalued, pricing in significant future benefits.

Sign up to view all

HON 12-Month Price Forecast

The outlook for HON is bifurcated, hinging entirely on the successful execution of its strategic transformation. The base case (55% probability) of a gradual grind higher towards analyst targets is most likely, assuming the spinoff proceeds without major hiccups. The bull case offers substantial upside but requires flawless execution and a supportive macro backdrop. The bear case, while lower probability, presents meaningful downside to the 52-week low if execution falters. The stance is neutral due to the offsetting forces of a compelling long-term story and near-term valuation/execution risks. Confidence is medium because the spinoff outcome is a known binary event, but its market reception is uncertain. The stance would upgrade to bullish on evidence of smooth spinoff progress and a return to revenue growth; it would turn bearish on further top-line deterioration or spinoff delays.

Historical Price
Current Price $231.24
Average Target $295
High Target $305
Low Target $186

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Honeywell's 12-month outlook, with a consensus price target around $300.61 and implied upside of +30.0% versus the current price.

Average Target

$300.61

7 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

7

covering this stock

Price Range

$185 - $301

Analyst target range

Buy
2 (29%)
Hold
3 (43%)
Sell
2 (29%)

Analyst coverage for Honeywell is substantial, with data indicating 7 analysts providing estimates, and recent institutional ratings showing active engagement from major firms. The consensus sentiment leans bullish, with recent actions including upgrades to 'Outperform' from Wolfe Research and maintained 'Overweight' or 'Buy' ratings from Barclays, Citigroup, and JP Morgan, balanced by 'Equal Weight' or 'Hold' ratings from Morgan Stanley, Jefferies, and Wells Fargo. The average target price is implied through estimated EPS; with a consensus EPS of $14.93 and a forward PE of 20.01x, the implied average price target is approximately $298.70, representing a significant +30% upside from the current price of $229.01. The target range, derived from EPS estimates, spans from a low of $14.60 to a high of $15.24, which at the forward PE implies a price range of roughly $292 to $305. The high target assumes successful execution of the spinoff, multiple expansion for both entities, and sustained margin performance, while the low target likely factors in integration risks, macroeconomic slowdown, or delays in realizing spinoff benefits. The relatively tight EPS range indicates strong analyst conviction in the near-term earnings trajectory, though the wide dispersion in ratings (Buy/Hold) reflects debate over the valuation and timing of the strategic moves.

Drowning in data?

Find the real signal!

Bulls vs Bears: HON Investment Factors

The investment debate for Honeywell is a classic tension between transformative strategic action and near-term operational execution. The bull case, currently supported by stronger evidence, is anchored on the significant value-unlocking potential of the Aerospace spinoff, robust underlying profitability, and analyst conviction in forward earnings. The bear case highlights real risks: recent revenue contraction, a premium valuation that prices in perfection, and high financial leverage. The single most important factor that will determine the thesis is the successful execution of the spinoff without further deterioration in the core business's top-line growth. If the separation proceeds smoothly and the new entities command higher multiples, the bull thesis prevails. If execution is messy or macro headwinds intensify, the premium multiple is at severe risk.

Bullish

  • Aerospace Spinoff Unlocking Value: The board-approved spinoff of the high-growth Aerospace unit is the central bullish narrative, designed to create two more focused entities. Analysts project this could lead to significant valuation expansion, with the implied average price target of ~$298.70 representing a +30% upside from the current price.
  • Strong Profitability & Cash Generation: Honeywell's fundamentals are robust, with a trailing net margin of 12.63% and an operating margin of 17.54%. The company generates substantial free cash flow ($5.39B TTM), supporting a healthy dividend (2.39% yield) and providing flexibility for the portfolio transition.
  • Analyst Conviction in Forward Earnings: Analysts show strong conviction in the near-term earnings trajectory, with a tight consensus EPS range of $14.60 to $15.24. The forward P/E of 20.01x, a discount to the trailing P/E of 26.36x, implies the market expects earnings growth, likely from spinoff benefits.
  • Defensive Profile with Low Beta: The stock's beta of 0.84 indicates it is 16% less volatile than the broader market, providing a defensive characteristic. This aligns with its industrial profile and recurring aftermarket revenue, which could be attractive if market volatility increases.

Bearish

  • Revenue Softness & Recent Decline: Recent financials show concerning softness, with Q4 2025 revenue of $9.76B representing a -3.28% year-over-year decline. This deceleration, particularly in the large Aerospace segment, suggests potential cyclical headwinds or portfolio transition disruption.
  • Premium Valuation with High Expectations: The stock trades at a premium with a trailing P/E of 26.36x, above typical industrial conglomerate ranges and its own historical band. This leaves little room for error; any disappointment in spinoff execution or earnings could trigger a painful multiple compression.
  • Elevated Debt Leverage: Honeywell's debt-to-equity ratio of 2.24 indicates a leveraged capital structure. While substantial FCF provides coverage, this leverage adds financial risk, especially during a period of strategic separation and potential economic slowdown.
  • Severe Relative Underperformance: The stock has significantly underperformed the market, with a 1-year price change of +9.51% versus the S&P 500's +24.99%, resulting in a relative strength reading of -15.48. This laggard status reflects investor skepticism about near-term growth and the spinoff timeline.

HON Technical Analysis

Honeywell's stock is in a pronounced downtrend from its recent highs, with the price currently sitting at $229.01, which is approximately 92% of its 52-week range ($186.76 to $248.18), indicating it is still trading closer to its highs despite recent weakness. The 1-year price change of +9.51% significantly underperforms the S&P 500's +24.99%, showing a relative strength reading of -15.48, which highlights the stock's defensive laggard status over the past year. Recent momentum has been negative and volatile, with a 1-month price change of +5.46% but a 3-month change of only +3.39%, suggesting any recent bounce lacks conviction and momentum is decelerating from the stronger 6-month gain of +15.02%. The divergence between the positive 1-month move and the weak 1-year performance signals a potential oversold bounce within a longer-term corrective phase, rather than a trend reversal. Key technical support is at the 52-week low of $186.76, while resistance is at the recent high of $248.18; a sustained break below support would signal a deeper correction, while reclaiming resistance would require a significant positive catalyst. The stock's beta of 0.84 indicates it is 16% less volatile than the broader market, which aligns with its defensive industrial profile and suggests smaller daily moves relative to the SPY.

Beta

0.84

0.84x market volatility

Max Drawdown

-17.0%

Largest decline past year

52-Week Range

$187-$248

Price range past year

Annual Return

+10.6%

Cumulative gain past year

PeriodHON ReturnS&P 500
1m-0.2%-2.2%
3m+3.6%+15.8%
6m+17.2%+6.4%
1y+10.6%+20.9%
ytd+18.1%+7.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

HON Fundamental Analysis

Honeywell's revenue trajectory shows signs of softness, with the most recent Q4 2025 revenue of $9.76 billion representing a -3.28% year-over-year decline, a deceleration from the stronger growth seen in prior quarters of 2025. Segment data indicates Aerospace was the largest contributor at $8.69 billion, but the overall multi-quarter trend points to potential cyclical headwinds or portfolio transition effects as the company prepares for its spinoff. The company remains solidly profitable, with Q4 2025 net income of $295 million and a gross margin of 35.56%, though this quarterly net income figure is notably lower than the $1.83 billion reported in Q3 2025. Full-year profitability metrics are healthy, with a trailing net margin of 12.63% and an operating margin of 17.54%, indicating the core business generates strong earnings despite the recent quarterly volatility. The balance sheet and cash flow position is robust, with a trailing twelve-month free cash flow of $5.39 billion, a current ratio of 1.32, and a return on equity of 30.63%, demonstrating high efficiency. However, the debt-to-equity ratio of 2.24 is elevated, indicating a leveraged capital structure that the upcoming spinoff may help to rationalize, while the substantial FCF provides ample capacity for dividends, buybacks, and internal investment.

Quarterly Revenue

$9.8B

2025-12

Revenue YoY Growth

-0.03%

YoY Comparison

Gross Margin

+0.35%

Latest Quarter

Free Cash Flow

$5.4B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Home And Building Technologies
Aerospace
Safety And Productivity Solutions

Open an Account, get $2 TSLA now!

Valuation Analysis: Is HON Overvalued?

Given the company's consistent profitability with a positive net margin of 12.63%, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 26.36x, while the forward PE is lower at 20.01x; this gap implies the market expects earnings growth, likely factoring in benefits from the Aerospace spinoff and operational improvements. Compared to sector averages, Honeywell's valuation presents a mixed picture: its trailing PE of 26.36x is above the typical industrial conglomerate range, suggesting a premium, while its Price-to-Sales ratio of 3.33x and EV/EBITDA of 17.88x need to be contextualized against its high-margin, asset-light business model and strong aftermarket revenue. The premium is partially justified by superior profitability metrics like its 30.63% ROE, but may also reflect a 'sum-of-the-parts' valuation anticipation ahead of the spinoff. Historically, the current trailing PE of 26.36x sits above the multi-year range evident in the historical ratios data, which has frequently fluctuated between the high teens and low 20s. Trading near the top of its own historical band suggests the market is pricing in optimistic expectations for the strategic transformation, leaving little room for error; a reversion to the mean could pressure the multiple if execution falters.

PE

26.4x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 18x~105x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

17.9x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: Honeywell faces risks from its elevated debt load, with a debt-to-equity ratio of 2.24, which could constrain financial flexibility during the complex spinoff process. Recent quarterly performance shows volatility, with Q4 2025 net income plummeting to $295M from $1.83B in Q3, and revenue declining -3.28% YoY, indicating potential cyclical pressure or integration challenges. The company's valuation premium (trailing P/E of 26.36x) is heavily dependent on sustained high profitability (12.63% net margin) and the anticipated benefits of the portfolio transformation; any stumble could trigger a significant derating.

Market & Competitive Risks: The primary market risk is valuation compression. The stock trades at a premium to its historical P/E range and the broader industrials sector, while recent news highlights inflation risks capping equity multiples. Its beta of 0.84 offers defensive characteristics but also means it may lag in strong bull markets, as evidenced by its -15.48 relative strength versus the S&P 500 over the past year. Competitive risks are inherent in its diversified segments, but the spinoff itself introduces execution and focus risks, as the market will soon value two separate entities on their own merits against more focused peers.

Worst-Case Scenario: The worst-case scenario involves a botched spinoff execution coinciding with a deeper industrial recession. This could lead to sustained revenue declines, margin contraction from fixed cost dis-synergies, and a rapid de-rating of the premium multiple. In this adverse scenario, the stock could re-test its 52-week low of $186.76, representing a downside of approximately -18.5% from the current price of ~$229. A reversion to a more typical historical P/E in the low 20s on lowered earnings estimates could push the stock even lower, implying a realistic maximum drawdown in the range of -20% to -30% from current levels.

FAQ

The key risks are, in order of severity: 1) Execution Risk: The complex Aerospace spinoff could be delayed, incur higher costs, or fail to deliver expected valuation benefits. 2) Financial Risk: An elevated debt-to-equity ratio of 2.24 increases leverage, and recent quarterly net income volatility ($295M in Q4 vs. $1.83B in Q3) raises concerns. 3) Operational Risk: Revenue contracted -3.28% YoY in the last quarter, indicating potential cyclical or competitive headwinds. 4) Valuation Risk: The stock's premium multiple (26.36x P/E) is vulnerable to compression if growth disappoints or market sentiment sours on industrials.

The 12-month forecast centers on a base case price target range of $292 to $298 (55% probability), aligned with analyst consensus. This assumes the Aerospace spinoff proceeds smoothly and the company meets its ~$14.93 EPS estimate. The bull case (30% probability) targets $298 to $305, requiring flawless spinoff execution and a return to growth. The bear case (15% probability) sees the stock falling to a range of $186 to $210, re-testing its 52-week low, if the spinoff encounters problems or a recession hits. The most likely outcome is the base case, driven by the gradual realization of spinoff benefits.

HON appears fairly valued to slightly overvalued based on its current fundamentals. Its trailing P/E of 26.36x is above its own historical range and typical for industrial conglomerates, suggesting a premium. This premium is justified by the market's anticipation of value creation from the upcoming Aerospace spinoff and the company's superior profitability metrics like its 30.63% ROE. The forward P/E of 20.01x implies the market expects earnings growth. In essence, the valuation is not cheap on an absolute basis but could be justified if the spinoff delivers the anticipated multiple expansion for both entities.

HON is a conditional buy, suitable primarily for patient investors with a multi-year horizon who believe in the value-unlocking potential of the Aerospace spinoff. The stock offers a compelling +30% upside to the average analyst target of ~$298.70, backed by strong profitability and cash flow. However, it carries significant near-term risks, including a premium valuation (26.36x P/E), recent revenue declines, and high execution risk around the corporate action. It is not a good buy for short-term traders or those seeking low-volatility income; it is a strategic bet on a successful corporate transformation.

HON is unequivocally a long-term investment, with a suggested minimum holding period of 2-3 years to fully realize the value from the corporate transformation. Its low beta (0.84) and dividend (2.39% yield) provide some defensive characteristics, but the stock's near-term trajectory will be volatile and news-driven around the spinoff. Short-term traders face high uncertainty from earnings volatility and event risk. Long-term investors can look through this noise to capture the potential sum-of-the-parts valuation uplift and benefit from the company's entrenched market positions and recurring revenue streams.